What is simethicone, what are its clinical uses, and what are its adverse effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Simethicone?

Simethicone is an anti-foaming (defoaming) agent that works by breaking down gas bubbles in the gastrointestinal tract, making them easier to eliminate. 1 It is not absorbed systemically and acts locally within the GI lumen.

Clinical Uses

Primary FDA-Approved Indication

  • Relief of pressure and bloating commonly referred to as gas 1
  • Available in various formulations including 180 mg softgel capsules 1

Off-Label Uses in Endoscopy

Simethicone is widely used off-label as an adjunct to improve mucosal visualization during gastrointestinal endoscopy procedures. 2

For Colonoscopy Preparation

  • The 2025 US Multi-Society Task Force on Colorectal Cancer recommends using at least 320 mg of simethicone if adding it to bowel preparation regimens 3
  • Doses of 320 mg or higher improve bowel preparation quality and reduce intraluminal bubbles 3
  • Reduces intraprocedural simethicone use from 49% to 2% of colonoscopies 3
  • Does NOT improve adenoma detection rates (ADR) in most studies, though some benefit may exist when baseline ADR is <25% 3
  • Significantly reduces abdominal bloating during preparation 4

Important caveat: The benefit is primarily seen with single-dose bowel preparations; split-dose preparations show less consistent improvement 4, 5

For Upper Endoscopy (EGD)

  • Oral administration 15-30 minutes before the procedure improves mucosal visualization 6, 7
  • Doses as low as 40 mg are effective when given 15-30 minutes pre-procedure 8
  • Split-dose regimen (20 mg at two time points) or early single administration (20-30 minutes before) provides optimal mucosal visibility 7
  • Reduces procedure time by improving visualization 7, 8
  • Can be combined with mucolytics like N-acetylcysteine for enhanced effect 2

For Capsule Endoscopy

  • 300 mg administered 20 minutes before the procedure improves small bowel mucosal visualization, particularly in the proximal small intestine 9

Side Effects and Safety Profile

Adverse Effects

Simethicone has an excellent safety profile with essentially no reported adverse effects in clinical studies. 10, 2, 9

  • No systemic absorption occurs
  • No significant adverse events reported in multiple large trials 10
  • Does not increase rates of:
    • Nausea 4
    • Vomiting 4
    • Abdominal pain 4
    • Bronchoaspiration risk 2
  • Actually DECREASES abdominal bloating compared to preparation without simethicone 4

Important Safety Considerations for Endoscopy Use

When using simethicone during endoscopy procedures (administered through endoscope channels), there are theoretical infection control concerns:

  • Simethicone residue can persist in endoscope channels despite high-level disinfection 6, 10
  • Theoretical risk of biofilm formation, though no actual infectious complications have been reported in clinical practice 10, 11

To minimize theoretical risks when using intraprocedural simethicone:

  • Use the lowest concentration (0.5% solution) and smallest volume 3, 6
  • Administer through the working channel rather than the waterjet channel 6
  • Ensure the working channel is routinely brushed during endoscope reprocessing 3, 6
  • Strict adherence to instrument reprocessing protocols is essential 10

Recent evidence shows reservoir simethicone use is NOT associated with increased post-procedure infection rates (0 vs 1 infection in 446 procedures, p=0.47) 11

Storage

  • Store at controlled room temperature 59°-86°F (15°-30°C) 1
  • Protect from light, moisture, and freezing 1

Key Clinical Pearls

  • Oral premedication is preferred over intraprocedural administration to avoid theoretical endoscope contamination concerns
  • Cost to patients should be considered when adding to bowel preparation regimens 3
  • The medication is safe, well-tolerated, and can improve procedural efficiency 11, 8
  • No dose adjustment needed for special populations as there is no systemic absorption

References

Research

Premedication in upper gastrointestinal endoscopy to improve mucosal visualization. A systematic review.

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 2024

Guideline

aga clinical practice update on high-quality upper endoscopy: expert review.

Clinical Gastroenterology and Hepatology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.